Όλο το DSpace

Πλοήγηση ανά Θέμα "belimumab"

Αποτελέσματα 1-3 από 3

    • Belimumab is a promising third-line treatment option for refractory autoimmune hepatitis 

      Arvaniti P., Giannoulis G., Gabeta S., Zachou K., Koukoulis G.K., Dalekos G.N. (2020)
      Background & Aims: Autoimmune hepatitis (AIH) is a disease of unknown aetiology with a favourable response to immunosuppression. However, in the clinic, it appears that <50% of patients achieve complete response on standard ...

    • Immunotherapy of systemic sclerosis 

      Katsiari C.G., Simopoulou T., Alexiou I., Sakkas L.I. (2018)
      Systemic sclerosis (SSc) is a chronic systemic disease characterized by microvasculopathy, immune activation, and extensive collagen deposition. Microvasculopathy and immune activation occur very early in the disease ...

    • Systemic sclerosis: From pathogenesis towards targeted immunotherapies 

      Sakkas, L. I.; Chikanza, I. C.; Platsoucas, C. D. (2012)
      Systemic sclerosis (SSc), a chronic disease with widespread collagen deposition, has three pathogenetic facets: immune activation, microvasculopathy and fibroblast activation. Immune activation and microvasculopathy occur ...